Quote from news articleRamos, along with two other ex-employees, are currently suing Folium for financial damages and equity in the company lawsuits that the company plans to fight, Calzada says. Lawsuits like these are par for the course when a company is going public, Calzada wrote in a text to anIndyreporter. They're a sign that Folium Biosciences is highly valuable and everyone wants a piece.